Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
0.75 GBX | 0.00% | 0.00% | -53.12% |
Apr. 26 | Evgen Pharma plc will Change its Ticker to TCF from EVG | CI |
Apr. 26 | Evgen Pharma plc will Change its Name to TheraCryf plc | CI |
Financials (USD)
Sales 2024 * | 497K | Sales 2025 * | - | Capitalization | 4.08M |
---|---|---|---|---|---|
Net income 2024 * | -4M | Net income 2025 * | -2M | EV / Sales 2024 * | 3.42 x |
Net cash position 2024 * | 2.38M | Net cash position 2025 * | 1.76M | EV / Sales 2025 * | - |
P/E ratio 2024 * |
-0.64
x | P/E ratio 2025 * |
-1.93
x | Employees | 10 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 67.58% |
1 month | -6.25% | ||
3 months | -28.57% | ||
6 months | -55.88% | ||
Current year | -53.12% |
Managers | Title | Age | Since |
---|---|---|---|
Huw Jones
CEO | Chief Executive Officer | 62 | - |
Toni Haenninen
DFI | Director of Finance/CFO | - | 23-09-04 |
Glen Clack
CTO | Chief Tech/Sci/R&D Officer | - | 21-04-30 |
Members of the board | Title | Age | Since |
---|---|---|---|
Huw Jones
CEO | Chief Executive Officer | 62 | - |
Susan Foden
CHM | Chairman | 71 | 14-11-20 |
Alan Barge
BRD | Director/Board Member | - | 15-10-20 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-23 | 0.75 | 0.00% | 186 220 |
24-05-22 | 0.75 | 0.00% | 1,586,661 |
24-05-21 | 0.75 | 0.00% | 0 |
24-05-20 | 0.75 | 0.00% | 371,653 |
24-05-17 | 0.75 | 0.00% | 26,775 |
Delayed Quote London S.E., May 23, 2024 at 06:59 am EDT
More quotesEPS Revisions
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.12% | 4.08M | |
+10.43% | 115B | |
+12.73% | 106B | |
-4.10% | 24.69B | |
-2.59% | 21.97B | |
-6.03% | 19.27B | |
-11.37% | 17.56B | |
-39.36% | 17.32B | |
+6.52% | 14.03B | |
+32.68% | 12.13B |
- Stock Market
- Equities
- EVG Stock